top of page
Companies in the News
BlackThorn Therapeutics Closes $76 Million Series B to Advance Targeted Therapeutics for Mental Heal
Company Also Expands Board of Directors and Executive Management Team with Key Appointments San Francisco – June 13, 2019 – BlackThorn...
Jun 13, 2019
Indigo launches The Terraton Initiative™ to remove one trillion tons of carbon dioxide from the atmo
At record levels of 415 parts per million (ppm), the Earth’s atmosphere contains one trillion tons (one teraton) more carbon dioxide...
Jun 12, 2019


A four-year-old start-up called Indigo Ag is the No. 1 company on the 2019 CNBC Disruptor 50 list
This Boston-based agricultural technology start-up is creating seed treatments that optimize the health of a plant in order to increase...
May 15, 2019
Vividion Secures $82 Million to Advance Its Lead Programs into the Clinic
Vividion Therapeutics snagged $82 million in an oversubscribed Series B funding round to bolster its cash holdings that will be used to...
Apr 30, 2019
Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immuno
EMERYVILLE, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), an immuno-oncology company developing...
Apr 22, 2019
BlackThorn Therapeutics Announces Positive Phase 1 Results for Its Selective KOR Antagonist, BTRX-33
Phase 1 results and new translational data supporting the development of BTRX-335140 for neurobehavioral disorders presented at the Kappa...
Apr 1, 2019
Indigo Agriculture and Anheuser-Busch Partner To Meet Sustainability Goals for Rice Production
BOSTON--(BUSINESS WIRE)--Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet, and...
Mar 11, 2019
Beam Brings In $135M to Turn CRISPR Base Editing into Drugs
Beam Therapeutics made a splash last year when it launched with $87 million to develop medicines that use a more precise form of CRISPR...
Mar 6, 2019
Gossamer Bio pulls off $276M IPO to push a trio of programs through the clinic
Late last month, Gossamer Bio filed to raise up to $230 million in a fixed-price IPO so it could go public despite the partial shutdown...
Feb 8, 2019
bottom of page